DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Fukuoka S, Hara H, Takahashi N, Kojima T, Kawazoe A, Asayama M. et al.
Regorafenib plus nivolumab in patients with advanced gastric or colorectal cancer: An open-label, dose-escalation, and dose-expansion phase Ib trial (REGONIVO, EPOC1603).
J Clin Oncol 2020;
38: 2053-61
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.